Employer uptake may be slowKaiser Family Foundation estimates that less than one-fifth of organizations with more than 200 employers covered GLP-1 drugs for weight management last yearbut demand is high
Conflict of Interest TK has received honoraria for lectures from AstraZeneca, Boehringer Ingelheim, Pharmaserve Lilly, and Novo Nordisk, for advisory boards from Novo Nordisk, and has participated in sponsored studies by Eli-Lilly and Novo Nordisk
Grey market products face the same risks multiplied by longer shipping times, less professional packaging, and zero quality monitoring during transit
GLP medications, often called GLP-1 receptor agonists, mimic the action of this naturally occurring hormone but stay active in the body much longer
Higher alcohol concentrations risk denaturing sensitive peptide bonds and disrupting tertiary structure, which is why this exact ratio has become the laboratory standard for peptide reconstitution work over several decades
Below, we provide a detailed summary of potential therapeutic strategies and discuss their possible clinical applications